Genomic medicine for cancer prognosis (Q38238835)

31 August 2017

title

Genomic medicine for cancer prognosis (English)

1 reference

31 August 2017

2

Martha A Zeiger

1 reference

31 August 2017

Aarti Mathur

1

1 reference

31 August 2017

publication date

11 August 2014

1 reference

Journal of Surgical Oncology

31 August 2017

published in

1 reference

31 August 2017

volume

111

1 reference

31 August 2017

issue

1

1 reference

31 August 2017

page(s)

31-37

1 reference

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

31 August 2017

cites work

1 reference

Thyroid cancer: burden of illness and management of disease

21 January 2018

1 reference

Prognostic utility of BRAF mutation in papillary thyroid cancer

21 January 2018

1 reference

Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers

21 January 2018

1 reference

BRAF mutation in thyroid cancer

21 January 2018

1 reference

The Raf/MEK/ERK pathway: new concepts of activation.

21 January 2018

1 reference

Reoperative central compartment dissection for patients with recurrent/persistent papillary thyroid cancer: efficacy, safety, and the association of the BRAF mutation

21 January 2018

1 reference

The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.

21 January 2018

1 reference

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

21 January 2018

1 reference

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

21 January 2018

1 reference

Molecular diagnostics and predictors in thyroid cancer

21 January 2018

1 reference

BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis

21 January 2018

1 reference

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

21 January 2018

1 reference

The prevalence and prognostic value of BRAF mutation in thyroid cancer

21 January 2018

1 reference

The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis

21 January 2018

1 reference

MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma

21 January 2018

1 reference

MicroRNA deregulation in human thyroid papillary carcinomas.

21 January 2018

1 reference

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

21 January 2018

1 reference

The role of microRNA genes in papillary thyroid carcinoma

21 January 2018

1 reference

miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation.

21 January 2018

1 reference

Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma

21 January 2018

1 reference

Prognostic value of BRAF mutations in localized cutaneous melanoma.

21 January 2018

1 reference

Prevalence of BRAF and NRAS mutations in fast-growing melanomas.

21 January 2018

1 reference

Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma

21 January 2018

1 reference

NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.

21 January 2018

1 reference

Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort.

21 January 2018

1 reference

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.

21 January 2018

1 reference

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

21 January 2018

1 reference

The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.

21 January 2018

1 reference

A "catastrophic hypothesis" for pancreas cancer progression

21 January 2018

1 reference

The National Cancer Data Base report on pancreatic cancer

21 January 2018

1 reference

SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer

21 January 2018

1 reference

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

21 January 2018

1 reference

Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy

21 January 2018

1 reference

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

21 January 2018

1 reference

Personalized medicine in pancreatic cancer: prognosis and potential implications for therapy

21 January 2018

1 reference

Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes

21 January 2018

1 reference

Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis

21 January 2018

1 reference

Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival

21 January 2018

1 reference

Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma

21 January 2018

1 reference

Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression

21 January 2018

1 reference

BRAF(V600E) mutation and the biology of papillary thyroid cancer

21 January 2018

1 reference

BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.23734

1 reference

31 August 2017

1 reference